PRA Health Sciences Inc

PRA Health Sciences — Q2 2016 Earnings Presentation

16 slides from PRA Health Sciences's earnings presentation, Jul 28, 2016

  1. Slide 1: Forward Looking Statements and Use of Non-GAAP Financial Measures

    Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains forward-looking statements that reflect, among other things, the Company’s current expectations and anticipated results of operations, all of which are subject to known and unknown risks, uncertainties and o

  2. Slide 2: Q2 2016 Highlights

    Q2 2016 Highlights ($ in millions, except per share amounts) $394.2 million of service revenue; 17.3% constant currency growth $38.7 million of GAAP Net Income; 211.5% growth compared to prior year $73.3 million of Adjusted EBITDA; 19.6% growth compared to prior year Adjusted Net Income per diluted

  3. Slide 3: Trailing Quarterly Performance

    Trailing Quarterly Performance Adjusted Income from Operations ($M) Adjusted EBITDA Margin (%) Service Revenue ($M) Adjusted EBITDA ($M) $40.6 $41.0 $45.2 $50.6 $56.2 $61.2 $62.4 $61.7 $67.4 Q2 2014 Q3 2014 Q4 2014 Q1 2015 Q2 2015 Q3 2015 Q4 2015 Q1 2016 Q2 2016 14.6% 14.7% 15.6% 16.8% 18.2% 19.3% 1

  4. Slide 4: Backlog and New Business Awards

    Backlog and New Business Awards Ending Backlog ($M) Backlog Conversion % Net Book-to-Bill Net New Business Awards ($M) 1.19 1.19 1.20 1.20 1.21 1.25 1.27 1.28 1.25 Q2 2014 Q3 2014 Q4 2014 Q1 2015 Q2 2015 Q3 2015 Q4 2015 Q1 2016 Q2 2016 $371.9 $382.1 $388.4 $398.0 $407.8 $431.4 $459.4 $476.2 $493.9 Q

  5. Slide 5: Debt Structure

    Debt Structure Weighted Average ($ in millions) June 30, September 30, December 31, March 31, June 30, Interest Maturity 2015 2015 2015 2016 2016 Rate Date Senior debt: First Lien 699.0 $ 689.0 $ 689.0 $ 689.0 $ 689.0 $ 4.50% September 23, 2020 Senior Notes 225.0 225.0 225.0 91.4 91.4 9.50% October

  6. Slide 6: Debt Structure

    | Debt Structure a a erie eal Maturity Date Senior debt: First Lien $698.0 $ 689.0 $ 689.0 $ 68.0 $ 688.0 4.50% September 23,2020 Senior Notes 225.0 2250 225.0 14 914 9.50% October 1, 2023, Total $940 $ 9140 $ 9140 $ 7804 $ 7804 Revolving credit: ‘Swingline $ - $ - $ - $ - $s - 5.25% September 23, 2

  7. Slide 7: Q2 and YTD 2016 Financial Results

    Q2 and YTD 2016 Financial Results ($ in millions) 2016 2015 % Change 2016 2015 % Change Service Revenue 394.2 $ 336.5 $ 17.2% 766.6 $ 668.5 $ 14.7% EBITDA 81.9 $ 52.7 $ 55.6% 93.0 $ 112.5 $ -17.3% Adjusted EBITDA 73.3 $ 61.3 $ 19.6% 140.7 $ 117.1 $ 20.2% Adjusted EBITDA Margin 18.6% 18.2% 18.4% 17.5

  8. Slide 8: Trailing Quarterly Performance

    Trailing Quarterly Performance Q2 16 v ($ in millions) Q2 15 % Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Q1 Q2 Change Service revenue 311.4 $ 311.3 $ 320.1 $ 323.8 $ 1,266.6 $ 332.0 $ 336.5 $ 345.1 $ 362.3 $ 1,375.8 $ 372.3 $ 394.2 $ 17.2% % growth Y-o-Y 87.0% 73.4% 70.2% 8.4% 52.1% 6.6% 8.1% 7.8% 11.9% 8.6% 12

  9. Slide 9: Backlog and New Business Awards

    Backlog and New Business Awards Q2 16 v ($ in millions) Q2 15 % Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Q1 Q2 Change Beginning Backlog 1,987.3 $ 2,044.8 $ 2,091.5 $ 1,939.7 $ 2,141.1 $ 2,185.3 $ 2,262.4 $ 2,348.4 $ 2,141.1 $ 2,440.1 $ 2,552.8 $ Ending Backlog 2,044.8 $ 2,091.5 $ 2,141.1 $ 2,141.1 $ 2,185.3 $ 2,2

  10. Slide 10: Reconciliation of GAAP Net Income to Adjusted Net Income

    Reconciliation of GAAP Net Income to Adjusted Net Income For further information regarding the reconciliation of non-GAAP measures to their corresponding GAAP equivalent please see our press release ($ in millions, except per share data) 2016 2015 2016 2015 Net income 38.7 $ 12.4 $ 22.7 $ 29.6 $ Amo

  11. Slide 11: Reconciliation of GAAP Net Income to Adjusted Net Income

    Reconciliation of GAAP Net Income to Adjusted Net Income For further information regarding the reconciliation of non-GAAP measures to their corresponding GAAP equivalent please see our press release ($ in millions, except per share data) 2016 2015 2016 2015 Net income 38.7 $ 12.4 $ 22.7 $ 29.6 $ Amo

  12. Slide 12: Reconciliation of GAAP Income from Operations to Adjusted Income from Operations

    Reconciliation of GAAP Income from Operations to Adjusted Income from Operations For further information regarding the reconciliation of non-GAAP measures to their corresponding GAAP equivalent please see our press release ($ in millions) 2016 2015 2016 2015 Income from operations 50.3 $ 38.3 $ 69.3

  13. Slide 13: Geographic Breakdown

    Geographic Breakdown ($ in millions) Region Q2 16 Q2 15 US/Canada 240.0 205.7 Europe/Africa 117.8 99.2 Latin America 15.9 13.8 Asia/Pacific 20.6 17.8 Grand Total 394.2 336.5 Region YTD 2016 YTD 2015 US/Canada 465.4 407.7 Europe/Africa 232.7 200.2 Latin America 29.8 27.3 Asia/Pacific 38.7 33.3 Grand

  14. Slide 14: Days Sales Outstanding

    Days Sales Outstanding ($ in millions) Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Accounts Receivable, net 246.0 $ 241.9 $ 236.1 $ 233.3 $ 239.6 $ 281.4 $ 281.9 $ 288.3 $ 285.7 $ 320.6 $ Unbilled Services 102.3 98.0 113.2 105.5 132.8 115.2 118.5 126.8 134.4 142.8 Total Accounts Receivable and Unbilled Services 3

  15. Slide 15: Days Sales Outstanding

    | Days Sales Outstanding (Sinnitons) 2014 2015 26 a o@ 8 @ wm e@ @ ww aw w ‘Accounts Receivable, net $ 60 $ 2419 $ 2361 $ 2333 $ 2396 $ B14 $ 219 $ 2883 $ 285.7 $ 3106 Untied Services 13 980 +1132 10551828 1152S HB Total AccountsReceivable and Unbiled Services 3483 3399—MO.3_ HRB T3966 © HOD ISA 0A

  16. Slide 16: PRA Health Sciences

    R\ 2 OS PRAHEALTHSCIENCES THE FUTURE OF CLINICAL DEVELOPME

PRA Health Sciences — Q2 2016 Earnings Presentation on 6ix